Viewing Study NCT04399551


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-25 @ 9:38 PM
Study NCT ID: NCT04399551
Status: COMPLETED
Last Update Posted: 2024-04-05
First Post: 2020-05-18
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
Sponsor: ViiV Healthcare
Organization: